According to a 2023 study, about 1% of Ozempic users and 0.7% of Saxenda users developed stomach paralysis, compared to 0.3% of those taking Contrave
adding a second agent targeting the same receptors does not increase receptor activation beyond the maximum achievable by one agent alone
Synergistic metabolic effects: The triple mechanism creates compounding benefits where each pathway amplifies others
This article makes the case that there is still much than can be done when it comes to affordability, education and access to quality midlife womens healthcare
Falutz J, Allas S, Mamputu JC, et al
Government hospitals: Where GLP-1s are available via tenders, they may be dispensed free or at heavily subsidised rates to selected high-risk patients, though this is still limited and uneven across states.[9] 4.3 Government Schemes and Insurance Ayushman Bharat (AB-PMJAY): As per recent parliamentary responses, there is currently no wide-scale inclusion of GLP-1 receptor agonists under AB-PMJAY packages.[5] State schemes: A few better-resourced state programmes and teaching institutions may provide GLP-1s to high-risk diabetes patients through special budgets or pilot projects, but this is not yet mainstream.[9] Private insurance: Most retail health insurance still focuses on hospitalisation, not long-term outpatient medicines
